AU2002240112A1 - Immunopolypeptides to hepatitis c virus - Google Patents

Immunopolypeptides to hepatitis c virus

Info

Publication number
AU2002240112A1
AU2002240112A1 AU2002240112A AU2002240112A AU2002240112A1 AU 2002240112 A1 AU2002240112 A1 AU 2002240112A1 AU 2002240112 A AU2002240112 A AU 2002240112A AU 2002240112 A AU2002240112 A AU 2002240112A AU 2002240112 A1 AU2002240112 A1 AU 2002240112A1
Authority
AU
Australia
Prior art keywords
immunopolypeptides
hepatitis
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002240112A
Inventor
Dennis R. Burton
Robert I. Fox
Ian M. Jones
Toshiaki Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2002240112A1 publication Critical patent/AU2002240112A1/en
Abandoned legal-status Critical Current

Links

AU2002240112A 2001-01-26 2002-01-25 Immunopolypeptides to hepatitis c virus Abandoned AU2002240112A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/264,451 2001-01-26

Publications (1)

Publication Number Publication Date
AU2002240112A1 true AU2002240112A1 (en) 2002-08-06

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
AU2002210450A1 (en) Maintaining virus detection software
HK1070287A1 (en) Hepatitis c virus inhibitors
AU2003206862A1 (en) Hepatitis b vaccines
AU7087901A (en) Modified virus
IL157251A0 (en) Hepatitis b virus treatment
AU2003294757A1 (en) Formulations useful against hepatitis c virus infections
AU2002225895A1 (en) Hepatitis c virus constructs characterized by high efficiency replication
AU2002243257A1 (en) Oncolytic virus
AU2003301865A1 (en) Epitopes of hepatitis c virus
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AUPR160400A0 (en) Plant virus promoter
AU2003256404A1 (en) Hepatitis c virus assays
AU2003248821A1 (en) Chimeric gb virus b (gbv-b)
AU2002240112A1 (en) Immunopolypeptides to hepatitis c virus
AU2002222139A1 (en) Hcv vaccines
WO2002083858A8 (en) Methods to inhibit viral replication
EP1290230A4 (en) Hepatitis c virus conjugates
AU2003230790A1 (en) Hepatitis c virus sub-genomic replicons
AU2002354841A1 (en) Engineering oncolytic viruses
AU2003221569A1 (en) Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon
AU2001282560A1 (en) Methods of infection with hepatitis c virus
AU2001254670A1 (en) Detection of hepatitis b virus rna
AU2002351795A1 (en) Hepatitis x virus antigen